All News
Filter News
Found 507,016 articles
-
After waiting with bated breath, Johnson & Johnson Innovation finally opened its New York City JLABS facility with 26 resident companies, including the four winners of the JLABS @ NYC QuickFire Challenge.
-
Autolus Brings in $150 Million in IPO, Continues Strong Investment Trend for Biotechs This Week
6/22/2018
Autolus Therapeutics snagged $150 million from its initial public offering, about $25 million more than the company initially expected when it began its roadshow effort earlier this month. -
June 22 Research Roundup: Diabetes, Spinal Injury, Pancreatic Cancer and Cardiovascular Disease
6/22/2018
There are plenty of great scientific research stories out this week including a possible cure for diabetes, healing spinal injury and more. -
Nanobiotix announced positive topline data from its Phase II/III clinical trial of NBTXR3 in soft tissue sarcoma (STS). Shares climbed by more than 50 percent at the news.
-
Chances are you already meet with your boss on a fairly regular basis to discuss the usual things like your progress on projects or goals, any roadblocks or challenges you’re facing, performance reporting for your department or team, and of course any housekeeping issues that need addressing.
-
We are living in a business climate of intense change and what seems to be a constant transition. It’s hard to keep up with all that’s going on while following the latest news.
-
Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA)
6/22/2018
Approximately 74,000 - 185,000 people in the United States and 200,000 - 500,000 people worldwide are affected by NL.
-
Siemens Healthineers Launches Acuson Sequoia to Address Industry Challenges in Ultrasound Imaging
6/22/2018
Entirely new system enables high-resolution imaging at greater depths without impacting real-time performance
-
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Tr...
6/22/2018
Impel expects to commence enrollment in the pivotal Phase 3 study evaluating the safety and tolerability of long-term, intermittent use of INP104 for the treatment of acute migraine headache in H2 2018. -
Proteomics International at American Diabetes Association 78th Scientific Sessions following new license deals for diabetic kidney disease predictive test in USA and Mexico
6/22/2018
Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has just signed license agreements for its world-leading PromarkerD predictive test for diabetic kidney disease with USA and Mexico partners.
-
Hkbu Scholars Invent Award-winning Medical Device for Safe Growth of Neural Stem Cells Using Nanotechnology
6/22/2018
The research team of Hong Kong Baptist University (HKBU) invented a medical device with a specific nanotechnology layer for the proliferation and differentiation of neural stem cells (NSCs) in vitro.
-
ThromboGenics Partners with Prevent Blindness at 2018 Focus on Eye Health National Summit in Washington DC
6/22/2018
ThromboGenics NV announces its participation and support of the seventh annual Prevent Blindness Focus on Eye Health National Summit
-
LumiThera LT-300 Device For Treating Dry Advanced Macular Degeneration Granted CE Mark
6/22/2018
The "CE" mark is the abbreviation for Conformité Européenne, meaning European Conformity.
-
OneSight To Open First-Ever New York City School-Based Vision Center In Brooklyn
6/22/2018
25 Percent of U.S. Students Have Undiagnosed Vision Problem, Center Will Help Additional 5,000 Children
-
A New Generation Of Coagulation Specialists Is Advancing Research With Support From CSL Behring Global Grant
6/22/2018
Named after coagulation therapy pioneer Prof. Norbert Heimburger, the grant has been awarded this year to researchers from France, Netherlands and the United States.
-
ImaginAb Reconstitutes Japanese Subsidiary
6/22/2018
Subsidiary's goal is to better realize partnering opportunities with Japanese pharmaceutical companies.
-
BIOQuébec and Triumvirate Environmental Join Forces to Promote and Facilitate the Implementation of Effective and Sustainable Laboratory Practices
6/22/2018
This partnership will provide BIOQuébec members with a discount calculated according to the total volume purchased from the company in the base year.
-
Glooko Releases New Version of Mobile App, Presents Usability Outcomes From Mobile Insulin Dosing System (MIDS) Study
6/22/2018
Insights to be shared this weekend at the 78th Scientific Sessions of American Diabetes Association
-
Prometic Presents New Data on NASH Drug Candidate PBI-4547
6/22/2018
New data suggest PBI-4547 offers potential as novel therapy for liver fibrosis, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD), diabetes and obesity
-
HeartSciences Named “Start-Up to Watch”
6/22/2018
“Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist.